DRDO, Indian Army conducts successful trials of Man Portable Anti-tank Guided Missile Weapon System

Man Portable Anti-tank Guided Missile (MPATGM) Weapon System, indigenously designed and developed by Defence Research & Development Organisation (DRDO), has been field evaluated in different flight configurations several times with the objective of proving the technology with high superiority.

DRDO is the premier agency under the Ministry of Defence of the Government of India, which develops defence technologies, systems/products that are required for Indian Armed Forces.

Notably, the system consisted of the MPATGM, Launcher, Target Acquisition System, and the Fire Control Unit.

Noteworthy, adequate number of missile firing trials have been successfully conducted towards achieving compliance of complete operational envelop as stipulated in the General Staff Qualitative Requirements (Infantry, Indian Army).

The Warhead Flight Trials were successfully conducted at the Pokhran Field Firing Range, Rajasthan on April 13, 2024.

Further, Missile performance and warhead performance were found to be remarkable.

Penetration trials of the Tandem Warhead System of MPATGM have been successfully completed and it is found capable of defeating modern armour protected Main Battle Tank.

Worth mentioning that the ATGM system is well-equipped with day/night and top attack capability.

Dual mode seeker functionality is a great value addition to the missile capability for tank warfare.

With this, technology development and successful demonstration have been concluded and the system is now ready for Final User Evaluation Trials leading towards its induction into the Indian Army.

India’s Defence Minister Shri Rajnath Singh has complimented the DRDO and the Indian Army for the successful trials of the system.

He termed it as an important step towards achieving self-reliance in advanced technology-based defence system development.

Secretary, Department of Defence R&D and Chairman DRDO Dr Samir V Kamat also congratulated the teams associated with the trials.

Source: https://pib.gov.in/